openPR Logo
Press release

Acer Secures 'Powered By Partner' Rights for Dadasaheb Phalke International Film Festival Awards 2025, Upholding the Legacy of Indian Cinema

10-03-2024 09:08 PM CET | Leisure, Entertainment, Miscellaneous

Press release from: ABNewswire

Acer Secures 'Powered By Partner' Rights for Dadasaheb Phalke

Acer has yet again assumed the coveted role of Powered By Partner for the prestigious Dadasaheb Phalke International Film Festival Awards 2025, marking the extension of its previously remarkable association.
Image: https://www.abnewswire.com/uploads/9db01d1c37a3fd4e5269e1cd193dd038.png

Mumbai, Maharashtra - India's rich cinematic heritage is set to be celebrated once again at Dadasaheb Phalke International Film Festival, as the 2025 edition proudly announces Acer as its 'Powered By' partner. Renowned for its exceptional range of laptops, desktops, monitors, consumer electronics, and appliances, Acer's cutting-edge technological expertise will be pivotal in this prestigious celebration of the Film and Entertainment Industry.

The most anticipated ceremony, Dadasaheb Phalke International Film Festival Awards 2025, will take place on February 20, 2025, in Mumbai, Maharashtra, in the presence of celebrities, media personnel, government delegates and heavyweights from the industry. This momentous occasion celebrates the rich heritage of Indian cinema commemorating the legacy of Dadasaheb Phalke Ji - The Father of Indian Cinema. The evening will be an opulent celebration of extraordinary accomplishments in cinema, saluting the unwavering dedication and hard work of 2024. This grand occasion will unite the Indian Film Industry, Indian Television Industry, and the International Film Fraternity under one illustrious roof.

Harish Kohli, President & Managing Director, Acer India, said " Continuing the 'Powered By Partner' position for the second year with the prestigious Dadasaheb Phalke International Film Festival Awards 2025 is a testament to Acer's commitment to empowering creativity through technology. We are proud to be part of a platform that celebrates the power of storytelling and the innovative spirit of India's entertainment industry. Our goal has always been to provide cutting-edge tools that inspire creators to bring their visions to life, and this partnership continues to reflect our dedication to supporting the arts and pushing the boundaries of what's possible. "

The continued partnership between Acer and DPIFF in 2025 represents a profound convergence, merging cutting-edge technology with the art of storytelling to honour and elevate creativity and excellence within the cinematic realm.

Abhishek Mishra, CEO of DPIFF and Consultative Committee Member of FCI into Ministry of Consumer Affairs, Food & PD, Government of India, commented on the association, stating, " It is with great pride that we renew our esteemed partnership with Acer for the second term at Dadasaheb Phalke International Film Festival. This continued collaboration underscores our mutual dedication to fostering excellence within the cinematic realm. Acer's pioneering technology has been instrumental in amplifying the festival's impact, and we eagerly anticipate the next chapter of our alliance. Their unwavering support not only elevates the festival's prestige but also enriches the creative journey, celebrating the art of cinema in its finest form. "

Recently, the IT and technology solutions giant Acer Group has announced the entry of Acerpure in India. Acer is looking to venture into the home electronics market, with plans in the pipeline to manufacture and export appliances such as Television, water and air purifiers, vacuum cleaners and more from India. Acer's commitment to innovation and DPIFF's mission to celebrate the pioneers of Indian cinema dovetail seamlessly in this association. From high-performance laptops with impeccable display quality to powerful desktops engineered for intensive video editing, Acer's solutions promise to enhance the efficiency and productivity of individuals across the spectrum of creative disciplines. DPIFF, with Acer's support, will continue to foster creativity and innovation by offering filmmakers and content creators the resources they need to excel in the digital age.

The 2025 ceremony features the theme 'A World Stage: The Global Legacy of Indian Cinema'. This theme honours the lasting impact of Indian films on global cinema, highlighting both their historical significance and contemporary relevance. It celebrates the worldwide recognition of Indian cinema and its contributions to the enrichment of international film culture. The platform aspires to harmonize both technical and mainstream accolades, ensuring that recognition is solely based on contributions to cinema. From illustrious megastars to emerging filmmakers, every individual will be honoured under one unified emblem.

ABOUT ACER

Founded in 1976, today Acer is one of the world's top ICT companies and has a presence in over 160 countries. As Acer looks into the future, it is focused on enabling a world where hardware, software, and services will fuse to open up new possibilities for consumers and businesses alike. From service-oriented technologies to the Internet of Things to gaming and virtual reality, Acer's employees are dedicated to the research, design, marketing, sale, and support of products and solutions that break barriers between people and technology. Please visit www.acer.com for more information.

ABOUT DADASAHEB PHALKE INTERNATIONAL FILM FESTIVAL (DPIFF)

Dadasaheb Phalke International Film Festival (DPIFF) was founded to carry forward the legacy of Late Shri Dhundiraj Govind Phalke, lovingly known as Dadasaheb Phalke - The Father of Indian Cinema. It is India's only independent international film festival, with a mission to celebrate the work of aspiring, young, independent & professional filmmakers. The aim is to honour the lifetime effort of Shri Dadasaheb Phalke ji and so, the festival celebrates the brilliance of the Indian film industry by making an effort to acknowledge and aid nascent projects by bringing them to mainstream audiences. DPIFF is a unique initiative intended to honour the Entertainment Industry and to appreciate creativity in the spectacular world of cinema.

For more information on Dadasaheb Phalke International Film Festival (DPIFF), visit: www.dpiff.in [http://www.dpiff.in/]

Official Announcement Source: https://www.instagram.com/p/DAiRTVMo4Vd/?igsh=MXQ1OXFteWtpaDVjZQ==

Media Contact
Company Name: Dadasaheb Phalke International Film Festival
Contact Person: Media Relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=acer-secures-powered-by-partner-rights-for-dadasaheb-phalke-international-film-festival-awards-2025-upholding-the-legacy-of-indian-cinema]
Country: India
Website: http://www.dpiff.in/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acer Secures 'Powered By Partner' Rights for Dadasaheb Phalke International Film Festival Awards 2025, Upholding the Legacy of Indian Cinema here

News-ID: 3677399 • Views:

More Releases from ABNewswire

How to Pick the Best Online Chemistry Tutoring Platform
How to Pick the Best Online Chemistry Tutoring Platform
Image: https://www.abnewswire.com/upload/2025/10/814f4b38d9855ce5fcc0509bfebaa240.jpg Choosing the right chemistry tutoring platform can make the difference between academic success and continued struggles with complex reactions and molecular structures. With students increasingly turning to digital solutions for personalized learning support, the online chemistry tutoring market has exploded with options promising everything from AI-powered progress tracking to virtual lab experiences that transform how learners approach this challenging subject. Essential Platform Features for Effective Online Chemistry Tutoring Modern chemistry tutoring
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our

All 5 Releases


More Releases for Acer

Urea Cycle Disorders Market to Expand at a Substantial Growth Rate During the Fo …
As per DelveInsight's assessment, the Urea Cycle Disorders Market is anticipated to grow in the coming years owing to the increasing incidence of Urea Care Disorders patients in the 7MM and the launch of emerging therapies in the market. Some of the key players involved in the development of novel drugs for the treatment of Urea Cycle Disorders include ACER-001 (Acer Therapeutics), AEB1102 (Aeglea BioTherapeutics), DTX301 (Ultragenyx Pharmaceutical), among others. DelveInsight's
Acer Therapeutics Inc. (NASDAQ: ACER) Investor Notice: Update in Lawsuit against …
A lawsuit is pending for certain investors in shares of Acer Therapeutics Inc. (NASDAQ: ACER) over potential securities laws violations by Acer Therapeutics Inc. Investors who purchased shares of Acer Therapeutics Inc. (NASDAQ: ACER), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The lawsuit was filed on July 01, 2019 against Acer Therapeutics Inc. (NASDAQ: ACER) over alleged violations of Federal Securities Laws.
Investigation announced for long-term Investors in shares of Acer Therapeutics I …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Acer Therapeutics Inc.. Investors who are current long term investors in Acer Therapeutics Inc. (NASDAQ: ACER) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in Acer Therapeutics Inc. (NASDAQ: ACER stocks follows a lawsuit
Investigation announced for Investors in NASDAQ: ACER over possible Wrongdoing a …
An investigation was announced for investors in shares of Acer Therapeutics Inc. (NASDAQ: ACER) concerning potential breaches of fiduciary duties by certain directors of Acer Therapeutics Inc. Investors who are current long term investors in Acer Therapeutics Inc. (NASDAQ: ACER) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in Acer
Deadline on August 30th coming up in Lawsuit for Investors in Acer Therapeutics …
The Shareholders Foundation announced that a deadline is coming up on August 30, 2019 in the lawsuit filed for certain investors of Acer Therapeutics Inc. (NASDAQ: ACER) over alleged securities laws violations by Acer Therapeutics Inc. Investors who purchased shares of Acer Therapeutics Inc. (NASDAQ: ACER) have certain options and there are strict and short deadlines running. Deadline: August 30, 2019. NASDAQ: ACER stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in shares of Acer Therapeutics Inc. (NASDAQ: ACER)
An investor, who purchased shares of Acer Therapeutics Inc. (NASDAQ: ACER), filed a lawsuit over alleged Securities Laws violations by Acer Therapeutics Inc.. Investors who purchased shares of Acer Therapeutics Inc. (NASDAQ: ACER) have certain options and for certain investors are short and strict deadlines running. Deadline: August 30, 2019. NASDAQ: ACER investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Newtown, MA based Acer Therapeutics Inc.,